While Wall Street often strives for good news, United Parcel Service, Inc.’s stock plummeted by 8.3% during Tuesday’s session. The abrupt decline followed the multinational company’s disappointing report of a 7.8% year-on-year decrease in fourth-quarter fiscal 2023 revenue to $24.92 billion, missing the estimated $25.43 billion. Furthermore, the company’s adjusted EPS experienced a sharp drop from $3.62 in Q4 2022 to $2.47. Alas, this was in line with the consensus, but investors remain unimpressed.
In light of these results, it is unsurprising to witness the fall of UPS shares to $145.04 on Tuesday. However, what could be the cause of the nosedive and what implications might this hold for the industry?
Gainers
-
Agape ATP Corporation
shares skyrocketed by 79% to $0.9120. - Pixelworks, Inc. experienced a substantial 56.8% rise to $2.3209 after the company forged a multi-year agreement with Walt Disney Studios.
- The shares of Agrify Corporation surged by 50.7% to $0.9120 after I-Tseng Jenny Chan disclosed a 49.99% stake in the company through a 13D filing.
- Rail Vision Ltd. advanced by 38.8% to $20.38 following the announcement of its innovative AI-based computer to be incorporated in its Main Line and Switch Yard systems.
- Inspire Veterinary Partners, Inc. rebounded by 38% to $0.2359 after a 24% decline on Monday. Impressively, the company recently filed a prospectus for an up to $5 million public offering.
- Sanmina Corporation witnessed a 36.7% surge to $69.21 subsequent to the company reporting first-quarter financial results that surpassed expectations and issuing second-quarter guidance above estimates.
- Selina Hospitality PLC climbed 20.8% to $0.4603.
- C3is Inc. shares leaped 19.1% to $0.1609 due to a 13G filing indicating a 9.1% stake by S.H.N. Financial.
- Brainstorm Cell Therapeutics Inc. rose 18.2% to $0.39.
- Kura Oncology, Inc. experienced a 16.1% climb to $21.60 after reporting preliminary ziftomenib combination data in acute myeloid leukemia.
- Petros Pharmaceuticals, Inc. gained 13.9% to $1.56 following a notable 25% increase on Monday. Intriguingly, Petros Pharmaceuticals recently announced the completion of the initial cohort of a Phase 2 equivalent self-selection study.
- Tivic Health Systems, Inc. rose by 13.1% to $1.55.
- Nuvve Holding Corp. secured a 12.7% gain to $3.5380 after winning a $16 million contract from Fresno EOC to ‘transition EV fleet without taxing the powergrid’.
- Commvault Systems, Inc. soared 11.6% to $91.01 following robust quarterly results.
- Helmerich & Payne, Inc. ascended by 11.6% to $40.49 subsequent to upbeat earnings.
- Merchants Bancorp surged 9.2% to $47.96. Raymond James analyst Daniel Tamayo upheld Merchants Bancorp with a Strong Buy and raised the price target from $44 to $55.
- Nayax Ltd. climbed 8.4% to $25.15.
- Corning Incorporated surged 8% to $33.62 following strong sales.
- General Motors Company gained 7.6% to $38.06 after reporting better-than-expected fourth-quarter financial results and issuing 2024 adjusted EPS guidance above estimates.
- Celestica Inc. rose 4.6% to $34.06 after reporting better-than-expected fourth-quarter financial results and issuing first-quarter guidance above estimates.
Losers
-
Baijiayun Group Ltd
shares plummeted 66.4% to $2.50. - Meiwu Technology Company Limited tumbled by 49% to $3.93.
- Sidus Space, Inc. witnessed a 42.7% fall to $4.9863 following the company’s announcement of the pricing of its public offering of 1,251,700 Class A shares at $4.50 per share.
- 60 Degrees Pharmaceuticals, Inc. fell by 40.1% to $0.31 after the company announced the pricing of a $2.4 million public offering.
- Palisade Bio, Inc. declined by 32% to $0.6550. Palisade Bio revealed the exercise of previously issued warrants for $2.5 million.
- Nyxoah S.A. dipped by 39% to $7.53 after a remarkable 31% surge on Monday.
- Revelation Biosciences, Inc.
Market Plunge: Stock Performance Recap
Shares Plummet Across the Board
Stocks took a nosedive today, with a multitude of companies across various sectors experiencing significant declines in share prices as the trading day unfolded.
- REVB shares dipped 28.4% to $9.30 after gaining around 32% on Monday.
- CALX declined 26.6% to $32.56 after the company issued first-quarter adjusted EPS and revenue guidance below estimates.
- ALRN dipped 25.4% to $4.53.